• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部应用咪喹莫特治疗期间浅表皮肤恶性肿瘤的炎性浸润性质

Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment.

作者信息

Wolf Ingrid H, Kodama Kazuo, Cerroni Lorenzo, Kerl Helmut

机构信息

Department of Dermatology, Medical University of Graz, Graz, Austria.

出版信息

Am J Dermatopathol. 2007 Jun;29(3):237-41. doi: 10.1097/01.dad.0000211531.33670.94.

DOI:10.1097/01.dad.0000211531.33670.94
PMID:17519620
Abstract

Topical imiquimod (IQ) is an effective treatment for genital warts and various malignant tumors of the skin. IQ acts through the Toll-like receptor 7 leading to the production of cytokines and chemokines such as interferons, interleukins, and growth factors. We investigated the composition of the inflammatory cell infiltrate before, during, and after the treatment of 10 superficial cutaneous malignancies (melanoma in situ (n = 4), melanoma metastasis (n = 1), squamous cell carcinoma in situ (n = 4), and basal cell carcinoma (n = 1) with 5% IQ cream. Immunophenotyping revealed in all cases during treatment an increased population of T-lymphocytes positive for CD3, CD4 and CD8, as well as a considerable number of cytotoxic cells (TIA-1+, granzyme B+) and plasmacytoid dendritic cells (CD 123+). These findings further support previous investigations that the antitumor effects of IQ result from an enhanced cytotoxic T-cell mediated immune response and from the recruitment of plasmacytoid dendritic cells to the skin. The population of infiltrative inflammatory cells was similar in all patients irrespective of the type of tumor.

摘要

局部应用咪喹莫特(IQ)是治疗尖锐湿疣和各种皮肤恶性肿瘤的有效方法。IQ通过Toll样受体7发挥作用,导致细胞因子和趋化因子的产生,如干扰素、白细胞介素和生长因子。我们研究了10例浅表皮肤恶性肿瘤(原位黑色素瘤(n = 4)、黑色素瘤转移灶(n = 1)、原位鳞状细胞癌(n = 4)和基底细胞癌(n = 1))在使用5% IQ乳膏治疗前、治疗期间和治疗后的炎性细胞浸润成分。免疫表型分析显示,在治疗期间的所有病例中,CD3、CD4和CD8阳性的T淋巴细胞数量增加,以及相当数量的细胞毒性细胞(TIA-1+、颗粒酶B+)和浆细胞样树突状细胞(CD123+)。这些发现进一步支持了先前的研究,即IQ的抗肿瘤作用源于细胞毒性T细胞介导的免疫反应增强以及浆细胞样树突状细胞向皮肤的募集。所有患者的浸润性炎性细胞群体相似,与肿瘤类型无关。

相似文献

1
Nature of inflammatory infiltrate in superficial cutaneous malignancies during topical imiquimod treatment.局部应用咪喹莫特治疗期间浅表皮肤恶性肿瘤的炎性浸润性质
Am J Dermatopathol. 2007 Jun;29(3):237-41. doi: 10.1097/01.dad.0000211531.33670.94.
2
Imiquimod for superficial and in situ skin malignancy.
Drug Ther Bull. 2009 Oct;47(10):113-6. doi: 10.1136/dtb.2009.09.0040.
3
Imiquimod in the treatment of actinic keratoses and other intraepithelial neoplasms.咪喹莫特治疗光化性角化病及其他上皮内肿瘤。
Int J Dermatol. 2002 May;41 Suppl 1:12-5. doi: 10.1111/j.1365-4632.2002.00019.x.
4
Viral and nonviral uses of imiquimod: a review.咪喹莫特在病毒和非病毒方面的应用:综述
J Cutan Med Surg. 2004 Sep-Oct;8(5):338-52. doi: 10.1007/s10227-005-0023-5.
5
Treatment of lentigo maligna (melanoma in situ) with the immune response modifier imiquimod.用免疫反应调节剂咪喹莫特治疗恶性雀斑样痣(原位黑素瘤)。
Arch Dermatol. 2005 Apr;141(4):510-4. doi: 10.1001/archderm.141.4.510.
6
Imiquimod 5 percent cream and the treatment of cutaneous malignancy.5%咪喹莫特乳膏与皮肤恶性肿瘤的治疗
Dermatol Online J. 2004 Jul 15;10(1):4.
7
Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.咪喹莫特 5%乳膏作为原位黑素瘤、恶性雀斑样痣型的一线或辅助治疗药物。
J Am Acad Dermatol. 2015 Jun;72(6):1047-53. doi: 10.1016/j.jaad.2015.02.008. Epub 2015 Mar 17.
8
Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.外用5%咪喹莫特乳膏治疗日光损伤皮肤原位黑素瘤并发侵袭性疾病。
Arch Dermatol. 2003 Jul;139(7):945-7. doi: 10.1001/archderm.139.7.945.
9
Characterization of the cellular infiltrate during successful topical treatment of lentigo maligna with imiquimod.咪喹莫特成功局部治疗恶性雀斑样痣过程中细胞浸润的特征分析
Br J Dermatol. 2004 Oct;151(4):903-6. doi: 10.1111/j.1365-2133.2004.06176.x.
10
Imiquimod treatment of lentigo maligna: an open-label study of 34 primary lesions in 32 patients.咪喹莫特治疗恶性雀斑样痣:一项针对32例患者34处原发性损害的开放标签研究。
Arch Dermatol. 2008 Jul;144(7):943-5. doi: 10.1001/archderm.144.7.943.

引用本文的文献

1
Recurrence of Quadruple Extramammary Paget's Disease after 12 Years: A Case Report and Literature Review.12年后乳腺外Paget病复发4例:病例报告及文献复习
Case Rep Dermatol. 2024 Jun 17;16(1):149-155. doi: 10.1159/000538675. eCollection 2024 Jan-Dec.
2
A Review of Immunocryosurgery and a Practical Guide to Its Applications.免疫冷冻手术综述及其应用实用指南
Diseases. 2021 Oct 14;9(4):71. doi: 10.3390/diseases9040071.
3
In vivo cancer vaccination: Which dendritic cells to target and how?体内癌症疫苗接种:针对哪种树突状细胞,以及如何接种?
Cancer Treat Rev. 2018 Dec;71:88-101. doi: 10.1016/j.ctrv.2018.10.012. Epub 2018 Oct 25.
4
Anti-Melanoma immunity and local regression of cutaneous metastases in melanoma patients treated with monobenzone and imiquimod; a phase 2 a trial.单苯甲醚和咪喹莫特治疗黑色素瘤患者的抗黑色素瘤免疫及皮肤转移灶局部消退;一项2a期试验
Oncoimmunology. 2018 Jan 15;7(4):e1419113. doi: 10.1080/2162402X.2017.1419113. eCollection 2018.
5
Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments.白细胞介素-23/辅助性T细胞17相关细胞因子在基底细胞癌中的表达及其对医学治疗的反应
PLoS One. 2017 Aug 22;12(8):e0183415. doi: 10.1371/journal.pone.0183415. eCollection 2017.
6
The Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell Lines.免疫调节小分子咪喹莫特可诱导袋獾面部肿瘤细胞系凋亡。
PLoS One. 2016 Dec 9;11(12):e0168068. doi: 10.1371/journal.pone.0168068. eCollection 2016.
7
Severe cutaneous and neurologic toxicity in melanoma patients during vemurafenib administration following anti-PD-1 therapy.抗 PD-1 治疗后应用 vemurafenib 时黑色素瘤患者出现严重皮肤和神经毒性。
Cancer Immunol Res. 2013 Dec;1(6):373-7. doi: 10.1158/2326-6066.CIR-13-0092.
8
A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin.局部炎症和中央记忆 T 细胞的联合作用增强了皮肤的免疫治疗。
J Immunol. 2012 Dec 15;189(12):5622-31. doi: 10.4049/jimmunol.1200709. Epub 2012 Nov 9.
9
Plasmacytoid dendritic cells in the tumor microenvironment: immune targets for glioma therapeutics.肿瘤微环境中的浆细胞样树突状细胞:神经胶质瘤治疗的免疫靶点。
Neoplasia. 2012 Aug;14(8):757-70. doi: 10.1593/neo.12794.
10
Roles of the immune system in skin cancer.免疫系统在皮肤癌中的作用。
Br J Dermatol. 2011 Nov;165(5):953-65. doi: 10.1111/j.1365-2133.2011.10507.x.